The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
TWST.COM Logo
  • Home
  • Experts
  • Reports
  • Products
  • News
  • About Us
  • Series
    • General Investing
    • Financial Services
    • Consumer
    • Industry & Services
    • Natural Resources
    • Healthcare
    • Technology
  • Contact Us

The Medicines Company

Related Interviews

Managing U.S. Growth Stocks Across the Market-Cap Spectrum
August 24, 2018
Muggia, William A.

A Tepid Outlook on Revenue Growth for Biopharmaceutical Companies
March 10, 2017
Amusa, Gbola

Investing Based on Exposure to Long-Term Trends
March 10, 2017
Jones, Elizabeth

Looking for Biopharmaceuticals with Disruptive Innovation and Medicines Initiatives
August 12, 2016
Amusa, Gbola

Interview with the Chairman and CEO: The Medicines Company (MDCO)
December 18, 2014

Strong Fundamentals in Biotech Justify Even Higher Valuation Levels
December 11, 2014

High Success Rates and Significant M&A in the Antibody Space
April 16, 2013

L.FRIDAY / P.SWANSON - KING INVESTMENT ADVISORS INC
November 14, 2005

Small Cap Biotechnology Companies: Russell Gilbertson - Roth Capital Partners Llc
July 28, 2003

Stuart Essig - Integra Lifesciences Holdings Corporation (iart)
November 01, 2002

Alan Henderson - Rehabcare Group Inc (rhb)
September 13, 2002

R.schwarzkopf / S.gleason - Kayne Anderson Rudnick Investment Mgmt Llc
February 25, 2002

Mark Frevert - Enron Wholesale Services (ene)
May 31, 2001

Charles Federico - Orthofix International Nv (ofix)
January 10, 2001

Lee C. Hamilton - Alla Investment Mgmt
August 10, 1998

Steel - An Obtuse Approach : Jordan M. Estra - Bt Alex. Brown Inc
July 20, 1998

Cart

Latest News

Bear Market Investing: Is There a Way to Profit During Tariff Turmoil?
Tariff Beating US Defense and Aerospace Stocks from Morningstar: “They Don’t Usually Get this Cheap”
Trump Tariff Stock Picks from Award Winning Morgan Stanley Analyst Team

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

Subscribe now!

Sign Up For Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews

Interview with the Chairman, President and CEO: Puma Biotechnology, Inc. (NASDAQ:PBYI)

Alan H. Auerbach

Published April 29, 2025 in Biotechnology, Pharmaceuticals and Medical Devices

Companies covered: PBYI

Buy ($25)

Interview with the President and CEO: NeurAxis, Inc. (NYSEAMERICAN:NRXS)

Brian Carrico

Published April 29, 2025 in Biotechnology, Pharmaceuticals and Medical Devices

Companies covered: NRXS

Buy ($25)

Interview with the Chairman and CEO: Mira Pharmaceuticals, Inc. (NASDAQ:MIRA) and Telomir Pharmaceuticals, Inc. (NASDAQ:TELO)

Erez Aminov

Published April 29, 2025 in Biotechnology, Pharmaceuticals and Medical Devices

Companies covered: TELO MIRA

Buy ($25)

Most Popular Reports

Biotechnology, Pharmaceuticals and Medical Devices

Published April 29, 2025

Topics covered: Biotechnology Pharmaceuticals Medical Devices

Buy ($175)

Dividend-Oriented Strategies

Published April 10, 2025

Topics covered: Dividend-Oriented Strategies

Buy ($175)

Industrial Equipment, Aerospace and Defense

Published March 28, 2025

Topics covered: Industrial Equipment, Aerospace and Defense

Buy ($175)

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the Chairman, President and CEO: Puma Biotechnology, Inc. (NASDAQ:PBYI)
Interview with the President and CEO: NeurAxis, Inc. (NYSEAMERICAN:NRXS)
Interview with the Chairman and CEO: Mira Pharmaceuticals, Inc. (NASDAQ:MIRA) and Telomir Pharmaceuticals, Inc. (NASDAQ:TELO)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Asymmetric Risk/Reward at Core of Multi-Asset Strategy
Dividend Growth Strategy Favors High-Quality Financials
Screening for 10% Dividend Growth Over 10 Years
ANALYST INTERVIEWS
Small Cap Med-Tech Names Are More Insulated from Tariff Fallout
Penumbra and AngioDynamics Among Top Med-Tech Sector Picks
Onshoring Drug Manufacturing Is Critical, But Not Easy
Subscribe Today!
Since 1963
© The Wall Street Transcript 2016, 2025
Terms and Conditions
Privacy Policy
 
 
https://www.twst.com/wp-admin/admin-ajax.php
  • Join now for free!
  • Already a member?

or create an account with a social network.

Join with Facebook
Join with Twitter
Join with Google
Join now! | Forgot password?

or login using a social network


Log in with Facebook
Log in with Twitter
Log in with Google